Boston Scientific Investors Seek Class Cert. In Stock Suit

By Sydney Price · April 24, 2023, 8:03 PM EDT

Investors claiming Boston Scientific Inc. misled them about the prospects of a medical device asked a Massachusetts federal judge who had trimmed a previous version of their complaint to certify their...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

In re Boston Scientific Corporation Securities Litigation

Case Number

Court

Massachusetts

Nature of Suit

Stockholders Suits

Date Filed

December 16, 2020

Recent Articles By Sydney

July 15, 2024
Walgreens Investor Sues Over Challenged Pharmacy Division
July 10, 2024
Skin Care Tech Co. Says Suit Shows 'Rough' Year, Not Fraud
July 08, 2024
UnitedHealth Brass Face Investor Suit Over Merger Probe
July 08, 2024
Medical Device Co. SeaStar Sued Over Regulatory Disclosures
July 02, 2024
Pharma Co. Scores Exit In Investor Suit Over Primate Imports
June 06, 2024
Pharma Co. Misled Investors On Seizure Drug Trial, Suit Says
May 15, 2024
UnitedHealth Concealed DOJ Merger Investigation, Suit Says
May 13, 2024
Biogen Investors Seek Class Cert. In Alzheimer's Drug Suit
May 08, 2024
Shockwave Medical Investor Challenges $13B Deal With J&J
May 07, 2024
Pharma Co. Falsely Touted Obesity Drug Results, Suit Claims